Jae Lyun Lee, Sang Joon Shin, Inkeun Park, Woo Kyun Bae, Shinkyo Yoon, In-Ho Kim, Hong Jae Chon, Byoung Young Shim, Jin Young Kim, Jung Hoon Kim, Joo-Hwan Park, Il Hwan Kim, Miso Kim, Kwonoh Park, Hyo Jin Lee. "Cabozantinib as subsequent therapy to an immune checkpoint-based therapy in renal cell carcinoma, phase 2 interventional study (AT ASIA, KCSG GU21-02).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.5_suppl.547